These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28181012)

  • 1. Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells.
    Mizoguchi T; Kasahara K; Yamashita T; Sasaki N; Yodoi K; Matsumoto T; Emoto T; Hayashi T; Kitano N; Yoshida N; Amin HZ; Hirata KI
    Heart Vessels; 2017 Jun; 32(6):768-776. PubMed ID: 28181012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells.
    Takata K; Kinoshita M; Okuno T; Moriya M; Kohda T; Honorat JA; Sugimoto T; Kumanogoh A; Kayama H; Takeda K; Sakoda S; Nakatsuji Y
    PLoS One; 2011; 6(11):e27644. PubMed ID: 22110705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Pediococcus acidilactici R037 on Serum Triglyceride Levels in Mice and Rats after Oral Administration.
    Ueda T; Tategaki A; Hamada K; Kishida H; Hosoe K; Morikawa H; Nakagawa K
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(1):41-47. PubMed ID: 29491271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression.
    Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E
    Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
    Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
    Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
    Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of orally administered probiotic Pediococcus acidilactici on the small and large intestine of weaning piglets. A qualitative and quantitative micro-anatomical study.
    Di Giancamillo A; Vitari F; Savoini G; Bontempo V; Bersani C; Dell'Orto V; Domeneghini C
    Histol Histopathol; 2008 Jun; 23(6):651-64. PubMed ID: 18366003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice.
    Hermansson A; Johansson DK; Ketelhuth DF; Andersson J; Zhou X; Hansson GK
    Circulation; 2011 Mar; 123(10):1083-91. PubMed ID: 21357823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice.
    Ren Y; Yang Y; Yang J; Xie R; Fan H
    Int Immunopharmacol; 2014 Jul; 21(1):247-54. PubMed ID: 24836681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
    Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
    Wu H; Lo Y; Chan A; Law KS; Mok MY
    Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of p38 and transforming growth factor β receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis.
    Gárate D; Rojas-Colonelli N; Peña C; Salazar L; Abello P; Pesce B; Aravena O; García-González P; Ribeiro CH; Molina MC; Catalán D; Aguillón JC
    Arthritis Rheum; 2013 Jan; 65(1):120-9. PubMed ID: 22972370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein-induced apoptotic dendritic cells as a novel therapy for atherosclerosis.
    Frodermann V; van Puijvelde GH; Wierts L; Lagraauw HM; Foks AC; van Santbrink PJ; Bot I; Kuiper J; de Jager SC
    J Immunol; 2015 Mar; 194(5):2208-18. PubMed ID: 25653425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reformulating Small Molecules for Cardiovascular Disease Immune Intervention: Low-Dose Combined Vitamin D/Dexamethasone Promotes IL-10 Production and Atheroprotection in Dyslipidemic Mice.
    Ospina-Quintero L; Jaramillo JC; Tabares-Guevara JH; Ramírez-Pineda JR
    Front Immunol; 2020; 11():743. PubMed ID: 32395119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity.
    Li Y; To K; Kanellakis P; Hosseini H; Deswaerte V; Tipping P; Smyth MJ; Toh BH; Bobik A; Kyaw T
    Circ Res; 2015 Jan; 116(2):245-54. PubMed ID: 25398236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.